NIKTIMVO® (axatilimab) approved by the Therapeutic Goods Administration (TGA) under Priority Review for the treatment of…
Category: News
Sandhills Medical Foundation, Inc., d/b/a Sandhills Medical Data Breach: Edelson Lechtzin LLP Launches Investigation into Exposure of Personal Information
National class action firm offering free case evaluations to individuals impacted by the Sandhills Medical cybersecurity…
139th Canton Fair Phase 3 Advances Toward a Better Life with New and Strengthened Product Zones
GUANGZHOU, China, May 3, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair)…
Smartee präsentiert klinische Innovationen im Bereich der Unterkieferrepositionierung und stärkt seine Präsenz in Europa auf dem EAS-Kongress 2026
BRÜSSEL, 3. Mai 2026 /PRNewswire/ — Smartee Denti-Technology, ein weltweit führender Innovator im Bereich transparenter Zahnspangen,…
La troisième phase de la 139e Foire de Canton se concentre sur l’amélioration de la vie avec des zones de produits nouvelles et renforcées
GUANGZHOU, Chine, 3 mai 2026 /PRNewswire/ — La 139e Foire chinoise des importations et des exportations…
Stealth BioTherapeutics Provides Commercial Launch Update and Pipeline Progress Across Mitochondrial Disease Portfolio
– FORZINITY™ (elamipretide) injection early commercial momentum demonstrates strong patient uptake and rapid access timelines –…
Altesa BioSciences Selected for Oral Presentation at the American Thoracic Society 2026 International Congress
Presentation details the impact of vapendavir on quality of life and lung function ATLANTA, April 30,…
Are You All In? Target ALS Goes "All In For ALS Awareness" with Campaign to Highlight the Community and Research Building a World Where Everyone Lives
NEW YORK, April 30, 2026 /PRNewswire/ — For ALS Awareness Month this May, Target ALS is…
Renibus Therapeutics Announces Oral Presentation on Phase 3 PROTECT Trial Data for RBT-1 at the American Association for Thoracic Surgery (AATS) Annual Meeting
Clinical study in cardiac surgery patients demonstrates favorable safety profile; exploratory analyses suggest potential benefit in…
Halozyme Appoints Darren Snellgrove as Chief Financial Officer
SAN DIEGO, April 30, 2026 /PRNewswire/ –Halozyme Therapeutics, Inc. (Nasdaq: HALO) (“Halozyme” or the “Company”) today…